You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

VILAZODONE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Vilazodone Hydrochloride, and what generic alternatives are available?

Vilazodone Hydrochloride is a drug marketed by Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa. and is included in five NDAs.

The generic ingredient in VILAZODONE HYDROCHLORIDE is vilazodone hydrochloride. There are fourteen drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the vilazodone hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vilazodone Hydrochloride

A generic version of VILAZODONE HYDROCHLORIDE was approved as vilazodone hydrochloride by TEVA PHARMS USA on September 30th, 2019.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VILAZODONE HYDROCHLORIDE?
  • What are the global sales for VILAZODONE HYDROCHLORIDE?
  • What is Average Wholesale Price for VILAZODONE HYDROCHLORIDE?
Drug patent expirations by year for VILAZODONE HYDROCHLORIDE
Recent Clinical Trials for VILAZODONE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Risk Benefit Statistics LLC
National Alliance on Mental Illness New Mexico
Montana State University

See all VILAZODONE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for VILAZODONE HYDROCHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for VILAZODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
VIIBRYD Tablets vilazodone hydrochloride 10 mg, 20 mg, and 40 mg 022567 5 2015-01-21

US Patents and Regulatory Information for VILAZODONE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Accord Hlthcare VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208209-001 Apr 27, 2021 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Apotex VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208228-001 Jul 7, 2023 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Alembic VILAZODONE HYDROCHLORIDE vilazodone hydrochloride TABLET;ORAL 208202-001 Jan 10, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.